US Patent 7875624 Modulating and measuring cellular adhesion
Patent 7875624 was granted and assigned to Novartis on January, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+206 characters)
Article
Patent abstract
Methods of using compounds having Structure I or the salts or tautomers of the compounds in the treatment of disorders relating to cell adhesion and metastatic processes are presented herein.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07875624 Modulating and measuring cellular adhesion US Patent 7875624 Modulating and measuring cellular adhesion
Infobox
Patent Number
0787562400
Patent Number
787562400
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078756240
Date of Patent
January 25, 2011
0Patent Application Number
110613860
Date Filed
February 18, 2005
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078756240
Date of Patent
January 25, 2011
0Patent Application Number
110613860
Date Filed
February 18, 2005
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07875624 Modulating and measuring cellular adhesion
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07875624
Date of patent
January 25, 2011
Patent application number
11061386
Date Filed
February 18, 2005
Patent primary examiner
Find more entities like US Patent 7875624 Modulating and measuring cellular adhesion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
